Comparison of Air QTM Intubating Airway Versus Ambu-Aura Intubating Laryngeal Mask
- Conditions
- ObesityAirway Management
- Interventions
- Device: Ambu-Aura intubating laryngeal maskDevice: Air-Q intubating laryngeal airway
- Registration Number
- NCT04195035
- Lead Sponsor
- Cairo University
- Brief Summary
Supraglottic airway devices are important tools for airway management. Supraglottic airway devices have been introduced into brief surgical interventions because they are less invasive than intubation and safer than mask to maintain the patency of airway after induction of anesthesia. They are inserted via the oral route and can be used in emergency conditions when tracheal intubation and mask anesthesia are challenging.
Air Q intubating airway and Ambu Aura intubating laryngeal mask are two Supraglottic airway devices that are widely used.
Aim of the work is to compare Air-Q intubating laryngeal airway versus Ambu-Aura intubating laryngeal mask regarding sealing pressure and Fiberoptic intubation in class II obese patients.
- Detailed Description
Randomized comparative trial that will be performed in Kasr Al Ainy hospital, Cairo University, Cairo, Egypt.ASA II patients from 20 to 50 years of age, undergoing minor surgry were included in this study. 40 patients will be allocated into 2 equal groups using computerized software and enclosed in sealed opaque envelopes:
GQ ( n=20 ): Where Air-Q intubating laryngeal airway will be used for ventilation \& intubation through fiberoptic bronchoscope.
GA ( n=20 ): Where Ambu-Aura intubating laryngeal mask will be used for ventilation \& intubation through fiberoptic bronchscope.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 40
- Patients aged 18-65 years old.
- Sex: both genders.
- With American society of anaesthesiologists (ASA) physical activity II.
- Scheduled for elective surgery under general anaesthesia requiring endotracheal tube.
- Class II obese patients (BMI 34.9 - 39.9 kg/m2).
- Surgery: short time procedures ≥ 60 minutes, ≤ 120 minutes e.g.: breast surgery, elbow or foot surgery.
-
• Patient refusal.
- Patients with any respiratory tract abnormalities as laryngeal masses & facial deformities as fracture mandible.
- Patients with risk of pulmonary aspiration as in full stomach patients.
- Patients at risk of regurgitation of gastric content as in gastroesophageal reflux disease (GERD) and pregnant females.
- Emergency operation.
- Patients with obstructive sleep apnea.
- Patients prepared for laparotomy or laparoscopic procedures.
- Patients with risk of bleeding.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ambu-Aura intubating laryngeal mask Ambu-Aura intubating laryngeal mask Ambu-Aura intubating laryngeal mask will be used for ventilation \& intubation through fiberoptic bronchscope. After complete muscle relaxation a suitable sized (according to the patient's weight and BMI) Ambu-Aura laryngeal mask will be lubricated inserted and the ventilator circuit will be connected to the device to ventilate the patient. The ventilator will be set with tidal volume 4-6 ml/kg at a respiratory rate 12-15 breath/minute to keep normocapnia (ETCO2=30-35 mmHg). Vitals (HR, ABP and O2 saturation) and ET CO2 will be recorded 5 minutes after device insertion. Then intubation using the fiberoptic bronchoscope will be started through the supraglottic device, laryngeal view grade will be recorded, success of endotracheal intubation through the device and time of intubation (time starting from disconnection of the circuit from the device to use the fiberoptic brochoscope for intubation till tube insertion in the trachea). Air-Q intubating laryngeal airway mask Air-Q intubating laryngeal airway Where Air-Q intubating laryngeal airway will be used for ventilation \& intubation through fiberoptic bronchoscope. After complete muscle relaxation a suitable sized (according to the patient's weight and BMI) Air-Q will be lubricated inserted and the ventilator circuit will be connected to the device to ventilate the patient. The ventilator will be set with tidal volume 4-6 ml/kg at a respiratory rate 12-15 breath/minute to keep normocapnia (ETCO2=30-35 mmHg). Vitals (HR, ABP and O2 saturation) and ET CO2were recorded 5 minutes after device insertion. Then intubation using the fiberoptic bronchoscope will be started through the supraglottic device, laryngeal view grade will be recorded, success of endotracheal intubation through the device and time of intubation (time starting from disconnection of the circuit from the device to use the fiberoptic brochoscope for intubation till tube insertion in the trachea).
- Primary Outcome Measures
Name Time Method airway seal pressure 1 minute Measuring the seal pressure above which the oropharyngeal leak through the supraglottic device will occur (1 minute after confirmation of successful insertion).
- Secondary Outcome Measures
Name Time Method Success rate of intubation by fiberoptic bronchoscope 1 minute The success of the ventilation will be determined based on visible chest expansion, adequate tidal volume and drawing of 6 successive ETCO2 waves.
Success rate 1 minute Success rate of device insertion
heart rate 2 hours • Stress response related to the device used
Laryngeal view grade. 1 minute Grade 1: only larynx was seen, Grade 2: larynx plus the posterior surface of epiglottis were seen. Grade 3: larynx and anterior tip of epiglottis were seen with \<50% visual obstruction of larynx.
Grade 4: epiglottis down folded and its anterior surface were seen with \>50% visual field obstruction.
Grade 5: complete down folding of epiglottis and the larynx could not be seen directlyarterial blood pressure 2 hours systolic and diastolic arterial blood pressure. • Stress response related to the device used.
Trial Locations
- Locations (1)
Cairo university
🇪🇬Cairo, Egypt